Brokers Issue Forecasts for MIRM Q2 Earnings
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Research analysts at HC Wainwright issued their Q2 2025 earnings estimates for shares of Mirum Pharmaceuticals in a report released on Monday, May 19th. HC Wainwright analyst S. Ramakanth forecasts that the company will post earnings per share of ($0.36) for the quarter. HC Wainwright currently has […]
